Biopharma's Biggest Challenge May Not Be Geopolitics
The biopharma industry faces significant challenges, but its biggest obstacle may not be geopolitical tensions. Insights from DCAT Value Chain suggest other factors could be more critical to the sector's future, highlighting the complexity of issues beyond international relations that impact biopharma's growth and innovation.
DCAT Value Chain Insights·



